The global Automated And Closed Cell Therapy Processing Systems market size was valued at US$ 963 million in 2024 and is forecast to a readjusted size of USD 3588 million by 2031 with a CAGR of 19.8% during review period.
Automated and closed cell therapy processing systems are specialized technologies used in the field of regenerative medicine and cell therapy. These systems refer to the use of automated technology and equipment to perform various steps involved in the manufacturing and processing of cell-based therapies. This includes processes such as cell isolation, expansion, culture, harvesting, and quality control. Automation aims to reduce variability, improve reproducibility, and enhance the efficiency of cell therapy production. By automating these processes, it becomes possible to achieve higher throughput, maintain sterility, and ensure consistency in the final product. Closed systems in cell therapy processing refer to the use of fully enclosed environments and devices that minimize the exposure of cells to the external environment throughout the manufacturing process. Closed systems are critical for maintaining the safety and quality of cell therapies by reducing the risk of microbial contamination and protecting the cells from exposure to harmful agents.
North America is the largest Automated and Closed Cell Therapy Processing Systems market, which has a share about 41%, followed by Asia-Pacific and Europe with a market share of 34% and 24%, respectively. In terms of product type, Non-Stem Cell Therapy is the largest segment, occupied for a share of 90%. And in terms of application, Industry is the largest segment, which has a share about 66%.
This report is a detailed and comprehensive analysis for global Automated And Closed Cell Therapy Processing Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automated And Closed Cell Therapy Processing Systems market size and forecasts, in consumption value ($ Million), 2020-2031
Global Automated And Closed Cell Therapy Processing Systems market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Automated And Closed Cell Therapy Processing Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Automated And Closed Cell Therapy Processing Systems market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automated And Closed Cell Therapy Processing Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automated And Closed Cell Therapy Processing Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Miltenyi Biotec, Thermo Fisher Scientific, Terumo, Merck, Fresenius Kabi, Sartorius, Lonza, Boyalife (ThermoGenesis), EurekaBio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Automated And Closed Cell Therapy Processing Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stem Cell Therapy
Non-Stem Cell Therapy
Market segment by Application
Academia
Industry
Market segment by players, this report covers
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Automated And Closed Cell Therapy Processing Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Automated And Closed Cell Therapy Processing Systems, with revenue, gross margin, and global market share of Automated And Closed Cell Therapy Processing Systems from 2020 to 2025.
Chapter 3, the Automated And Closed Cell Therapy Processing Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Automated And Closed Cell Therapy Processing Systems market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Automated And Closed Cell Therapy Processing Systems.
Chapter 13, to describe Automated And Closed Cell Therapy Processing Systems research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Automated And Closed Cell Therapy Processing Systems by Type
1.3.1 Overview: Global Automated And Closed Cell Therapy Processing Systems Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Automated And Closed Cell Therapy Processing Systems Consumption Value Market Share by Type in 2024
1.3.3 Stem Cell Therapy
1.3.4 Non-Stem Cell Therapy
1.4 Global Automated And Closed Cell Therapy Processing Systems Market by Application
1.4.1 Overview: Global Automated And Closed Cell Therapy Processing Systems Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Academia
1.4.3 Industry
1.5 Global Automated And Closed Cell Therapy Processing Systems Market Size & Forecast
1.6 Global Automated And Closed Cell Therapy Processing Systems Market Size and Forecast by Region
1.6.1 Global Automated And Closed Cell Therapy Processing Systems Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Automated And Closed Cell Therapy Processing Systems Market Size by Region, (2020-2031)
1.6.3 North America Automated And Closed Cell Therapy Processing Systems Market Size and Prospect (2020-2031)
1.6.4 Europe Automated And Closed Cell Therapy Processing Systems Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size and Prospect (2020-2031)
1.6.6 South America Automated And Closed Cell Therapy Processing Systems Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Cytiva
2.1.1 Cytiva Details
2.1.2 Cytiva Major Business
2.1.3 Cytiva Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.1.4 Cytiva Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Cytiva Recent Developments and Future Plans
2.2 Miltenyi Biotec
2.2.1 Miltenyi Biotec Details
2.2.2 Miltenyi Biotec Major Business
2.2.3 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.2.4 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Miltenyi Biotec Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.3.4 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Terumo
2.4.1 Terumo Details
2.4.2 Terumo Major Business
2.4.3 Terumo Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.4.4 Terumo Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Terumo Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.5.4 Merck Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Merck Recent Developments and Future Plans
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.6.4 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Fresenius Kabi Recent Developments and Future Plans
2.7 Sartorius
2.7.1 Sartorius Details
2.7.2 Sartorius Major Business
2.7.3 Sartorius Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.7.4 Sartorius Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Sartorius Recent Developments and Future Plans
2.8 Lonza
2.8.1 Lonza Details
2.8.2 Lonza Major Business
2.8.3 Lonza Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.8.4 Lonza Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Lonza Recent Developments and Future Plans
2.9 Boyalife (ThermoGenesis)
2.9.1 Boyalife (ThermoGenesis) Details
2.9.2 Boyalife (ThermoGenesis) Major Business
2.9.3 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.9.4 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Boyalife (ThermoGenesis) Recent Developments and Future Plans
2.10 EurekaBio
2.10.1 EurekaBio Details
2.10.2 EurekaBio Major Business
2.10.3 EurekaBio Automated And Closed Cell Therapy Processing Systems Product and Solutions
2.10.4 EurekaBio Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 EurekaBio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Automated And Closed Cell Therapy Processing Systems Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Automated And Closed Cell Therapy Processing Systems by Company Revenue
3.2.2 Top 3 Automated And Closed Cell Therapy Processing Systems Players Market Share in 2024
3.2.3 Top 6 Automated And Closed Cell Therapy Processing Systems Players Market Share in 2024
3.3 Automated And Closed Cell Therapy Processing Systems Market: Overall Company Footprint Analysis
3.3.1 Automated And Closed Cell Therapy Processing Systems Market: Region Footprint
3.3.2 Automated And Closed Cell Therapy Processing Systems Market: Company Product Type Footprint
3.3.3 Automated And Closed Cell Therapy Processing Systems Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Automated And Closed Cell Therapy Processing Systems Consumption Value and Market Share by Type (2020-2025)
4.2 Global Automated And Closed Cell Therapy Processing Systems Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Automated And Closed Cell Therapy Processing Systems Consumption Value Market Share by Application (2020-2025)
5.2 Global Automated And Closed Cell Therapy Processing Systems Market Forecast by Application (2026-2031)
6 North America
6.1 North America Automated And Closed Cell Therapy Processing Systems Consumption Value by Type (2020-2031)
6.2 North America Automated And Closed Cell Therapy Processing Systems Market Size by Application (2020-2031)
6.3 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country
6.3.1 North America Automated And Closed Cell Therapy Processing Systems Consumption Value by Country (2020-2031)
6.3.2 United States Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
6.3.3 Canada Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
6.3.4 Mexico Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems Consumption Value by Type (2020-2031)
7.2 Europe Automated And Closed Cell Therapy Processing Systems Consumption Value by Application (2020-2031)
7.3 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country
7.3.1 Europe Automated And Closed Cell Therapy Processing Systems Consumption Value by Country (2020-2031)
7.3.2 Germany Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
7.3.3 France Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
7.3.5 Russia Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
7.3.6 Italy Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region
8.3.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Consumption Value by Region (2020-2031)
8.3.2 China Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8.3.3 Japan Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8.3.4 South Korea Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8.3.5 India Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
8.3.7 Australia Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
9 South America
9.1 South America Automated And Closed Cell Therapy Processing Systems Consumption Value by Type (2020-2031)
9.2 South America Automated And Closed Cell Therapy Processing Systems Consumption Value by Application (2020-2031)
9.3 South America Automated And Closed Cell Therapy Processing Systems Market Size by Country
9.3.1 South America Automated And Closed Cell Therapy Processing Systems Consumption Value by Country (2020-2031)
9.3.2 Brazil Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
9.3.3 Argentina Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country
10.3.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Consumption Value by Country (2020-2031)
10.3.2 Turkey Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
10.3.4 UAE Automated And Closed Cell Therapy Processing Systems Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Automated And Closed Cell Therapy Processing Systems Market Drivers
11.2 Automated And Closed Cell Therapy Processing Systems Market Restraints
11.3 Automated And Closed Cell Therapy Processing Systems Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Automated And Closed Cell Therapy Processing Systems Industry Chain
12.2 Automated And Closed Cell Therapy Processing Systems Upstream Analysis
12.3 Automated And Closed Cell Therapy Processing Systems Midstream Analysis
12.4 Automated And Closed Cell Therapy Processing Systems Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
听
听
*If Applicable.
